Marker Therapeutics, Inc. (MRKR)

1.71 -0.12 (-6.56%) USD  |  NASDAQ  |  Jan 13, 16:00
1.66 -0.05 (-2.92%) After-Hours: 20:00
More

Marker Therapeutics Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. --
Neurocrine Biosciences, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
AIM ImmunoTech, Inc. --